טוען...
Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
Liver cancers are the second most frequent cause of global cancer-related mortality of which 90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening programmes for patients with known risk factors, a substantial number of patients are ineligible for curative surgery a...
שמור ב:
| הוצא לאור ב: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718039/ https://ncbi.nlm.nih.gov/pubmed/31528090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i32.4614 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|